Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Neutrophil Cathepsin G and Tumor Cell RAGE Facilitate Neutrophil Anti-Tumor Cytotoxicity.

Sionov RV, Fainsod-Levi T, Zelter T, Polyansky L, Pham CT, Granot Z.

Oncoimmunology. 2019 Jun 11;8(9):e1624129. doi: 10.1080/2162402X.2019.1624129. eCollection 2019.

PMID:
31428521
2.

The Role of Neutrophil Proteins on the Amyloid Beta-RAGE Axis.

Stock AJ, Kasus-Jacobi A, Wren JD, Sjoelund VH, Prestwich GD, Pereira HA.

PLoS One. 2016 Sep 27;11(9):e0163330. doi: 10.1371/journal.pone.0163330. eCollection 2016.

3.

RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs).

Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami MM, Schmidt AM, Stern DM, Al-Mohanna FA.

J Leukoc Biol. 2002 Mar;71(3):433-44.

PMID:
11867681
4.

Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing.

Tadié JM, Bae HB, Banerjee S, Zmijewski JW, Abraham E.

Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C249-56. doi: 10.1152/ajpcell.00302.2011. Epub 2011 Oct 19.

5.

Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE).

Ichiki T, Koga T, Okuno T, Saeki K, Yamamoto Y, Yamamoto H, Sakaguchi M, Yokomizo T.

FASEB J. 2016 May;30(5):1811-22. doi: 10.1096/fj.201500117. Epub 2016 Jan 26.

PMID:
26813973
6.

Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix.

Touré F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, Vitry F, Chanard J, Gillery P, Rieu P.

Biochem J. 2008 Dec 1;416(2):255-61. doi: 10.1042/BJ20080054.

PMID:
18643777
7.
8.

A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin.

Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, Ballantyne CM, Gahmberg CG, Bianchi ME, Nawroth PP, Chavakis T.

EMBO J. 2007 Feb 21;26(4):1129-39. Epub 2007 Feb 1.

9.
10.

Neutrophil cathepsin G modulates platelet P-selectin expression and inhibits P-selectin-mediated platelet-neutrophil adhesion.

Ilton MK, Taylor ML, Misso NL, Thompson PJ, Hung J.

Clin Sci (Lond). 1998 Apr;94(4):437-45.

PMID:
9640350
11.

Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE).

Murakami Y, Fujino T, Kurachi R, Hasegawa T, Usui T, Hayase F, Watanabe H.

Biosci Biotechnol Biochem. 2018 Sep;82(9):1508-1514. doi: 10.1080/09168451.2018.1475213. Epub 2018 May 26.

PMID:
29804507
12.

Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.

Sharma AK, LaPar DJ, Stone ML, Zhao Y, Kron IL, Laubach VE.

Am J Transplant. 2013 Sep;13(9):2255-67. doi: 10.1111/ajt.12368. Epub 2013 Jul 19.

13.

Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.

Malik P, Chaudhry N, Mittal R, Mukherjee TK.

Biochim Biophys Acta. 2015 Sep;1850(9):1898-904. doi: 10.1016/j.bbagen.2015.05.020. Epub 2015 May 29. Review.

PMID:
26028296
15.

Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils.

Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, Wang JM, Howard OM, Sayers TJ, Oppenheim JJ.

J Exp Med. 1997 Aug 29;186(5):739-47.

16.

The receptor for advanced glycation end products (RAGE) contributes to the progression of emphysema in mice.

Sambamurthy N, Leme AS, Oury TD, Shapiro SD.

PLoS One. 2015 Mar 17;10(3):e0118979. doi: 10.1371/journal.pone.0118979. eCollection 2015.

17.

The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin.

Lomas DA, Stone SR, Llewellyn-Jones C, Keogan MT, Wang ZM, Rubin H, Carrell RW, Stockley RA.

J Biol Chem. 1995 Oct 6;270(40):23437-43.

18.

Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G.

Gardiner EE, De Luca M, McNally T, Michelson AD, Andrews RK, Berndt MC.

Blood. 2001 Sep 1;98(5):1440-7.

PMID:
11520793
19.

Participation of the receptor for advanced glycation end products in efferocytosis.

Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A, Abraham E.

J Immunol. 2011 Jun 1;186(11):6191-8. doi: 10.4049/jimmunol.1004134. Epub 2011 Apr 18.

20.

Advanced Glycated End Products Alter Neutrophil Effect on Regulation of CD4+ T Cell Differentiation Through Induction of Myeloperoxidase and Neutrophil Elastase Activities.

Lu H, Xu S, Liang X, Dai Y, Huang Z, Ren Y, Lin J, Liu X.

Inflammation. 2019 Apr;42(2):559-571. doi: 10.1007/s10753-018-0913-5.

PMID:
30343390

Supplemental Content

Support Center